UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

SCHEDULE 13D

 

Under the Securities Exchange Act of 1934
(Amendment No. 2)*

 

Millendo Therapeutics, Inc.

(Name of Issuer)

 

Common Stock, par value $0.001 per share

(Title of Class of Securities)

 

60040X103

(CUSIP Number)

 

Sophie Paquin

Bpifrance Participations S.A.

6-8, boulevard Haussmann

75009 Paris

France

+33 1 53 89 55 73

 

With copy to:

John C. Partigan

Nixon Peabody LLP

799 9th Street NW, Suite 500

Washington, DC 20001

(202) 585-8000

((Name, Address and Telephone Number of Person

Authorized to Receive Notices and Communications)

 

July 23, 2020

(Date of Event Which Requires Filing of this Statement)

 

If the filing person has previously filed a statement on Schedule 13G to report the acquisition that is the subject of this Schedule 13D, and is filing this schedule because of §§ 240.13d-1(e), 240.13d-1(f) or 240.13d-1(g), check the following box o.

 

Note:  Schedules filed in paper format shall include a signed original and five copies of the schedule, including all exhibits. See Rule 13d-7 for other parties to whom copies are to be sent.

 

*The remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter disclosures provided in a prior cover page.

 

The information required on the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act.

 

 

 


 

CUSIP No. 60040X103

 

1

Name of Reporting Person
Fonds Innobio FPCI

 

 

2

Check the Appropriate Box if a Member of a Group (See Instructions)

 

 

(a)

o

 

 

(b)

o

 

 

3

SEC Use Only

 

 

 

 

4

Source of Funds
WC

 

 

 

 

5

Check Box if Disclosure of Legal Proceedings Is Required Pursuant to Items 2(d) or 2(e) o

 

 

 

 

6

Citizenship or Place of Organization
France

 

 

 

Number of
Shares
Beneficially
Owned by
Each
Reporting
Person With

7

Sole Voting Power
0

 

8

Shared Voting Power
590,105

 

9

Sole Dispositive Power
0

 

10

Shared Dispositive Power
590,105

 

 

11

Aggregate Amount Beneficially Owned by Each Reporting Person
590,105

 

 

12

Check Box if the Aggregate Amount in Row (11) Excludes Certain Shares (See Instructions)  o

 

 

13

Percent of Class Represented by Amount in Row (11)
3.1%

 

 

14

Type of Reporting Person (See Instructions)
OO

 

2


 

CUSIP No. 60040X103

 

1

Name of Reporting Person
Bpifrance Investissement S.A.S.

 

 

2

Check the Appropriate Box if a Member of a Group (See Instructions)

 

 

(a)

o

 

 

(b)

o

 

 

3

SEC Use Only

 

 

 

 

4

Source of Funds
WC

 

 

 

 

5

Check Box if Disclosure of Legal Proceedings Is Required Pursuant to Items 2(d) or 2(e) o

 

 

 

 

6

Citizenship or Place of Organization
France

 

 

 

Number of
Shares
Beneficially
Owned by
Each
Reporting
Person With

7

Sole Voting Power
0

 

8

Shared Voting Power
590,105

 

9

Sole Dispositive Power
0

 

10

Shared Dispositive Power
590,105

 

 

11

Aggregate Amount Beneficially Owned by Each Reporting Person
590,105

 

 

12

Check Box if the Aggregate Amount in Row (11) Excludes Certain Shares (See Instructions)  o

 

 

13

Percent of Class Represented by Amount in Row (11)
3.1%

 

 

14

Type of Reporting Person (See Instructions)
OO

 

3


 

CUSIP No. 60040X103

 

1

Name of Reporting Person
Bpifrance Participations S.A.

 

 

2

Check the Appropriate Box if a Member of a Group (See Instructions)

 

 

(a)

o

 

 

(b)

o

 

 

3

SEC Use Only

 

 

 

 

4

Source of Funds
WC

 

 

 

 

5

Check Box if Disclosure of Legal Proceedings Is Required Pursuant to Items 2(d) or 2(e) o

 

 

 

 

6

Citizenship or Place of Organization
France

 

 

 

Number of
Shares
Beneficially
Owned by
Each
Reporting
Person With

7

Sole Voting Power
0

 

8

Shared Voting Power
590,105

 

9

Sole Dispositive Power
0

 

10

Shared Dispositive Power
590,105

 

 

11

Aggregate Amount Beneficially Owned by Each Reporting Person
590,105

 

 

12

Check Box if the Aggregate Amount in Row (11) Excludes Certain Shares (See Instructions)  o

 

 

13

Percent of Class Represented by Amount in Row (11)
3.1%

 

 

14

Type of Reporting Person (See Instructions)
OO

 

4


 

CUSIP No. 60040X103

 

1

Name of Reporting Person
Caisse des Dépôts

 

 

2

Check the Appropriate Box if a Member of a Group (See Instructions)

 

 

(a)

o

 

 

(b)

o

 

 

3

SEC Use Only

 

 

 

 

4

Source of Funds
WC

 

 

 

 

5

Check Box if Disclosure of Legal Proceedings Is Required Pursuant to Items 2(d) or 2(e) o

 

 

 

 

6

Citizenship or Place of Organization
France

 

 

 

Number of
Shares
Beneficially
Owned by
Each
Reporting
Person With

7

Sole Voting Power
0

 

8

Shared Voting Power
590,105

 

9

Sole Dispositive Power
0

 

10

Shared Dispositive Power
590,105

 

 

11

Aggregate Amount Beneficially Owned by Each Reporting Person
590,105

 

 

12

Check Box if the Aggregate Amount in Row (11) Excludes Certain Shares (See Instructions)  o

 

 

13

Percent of Class Represented by Amount in Row (11)
3.1%

 

 

14

Type of Reporting Person (See Instructions)
OO

 

5


 

CUSIP No. 60040X103

 

1

Name of Reporting Person
EPIC Bpifrance

 

 

2

Check the Appropriate Box if a Member of a Group (See Instructions)

 

 

(a)

o

 

 

(b)

o

 

 

3

SEC Use Only

 

 

 

 

4

Source of Funds
WC

 

 

 

 

5

Check Box if Disclosure of Legal Proceedings Is Required Pursuant to Items 2(d) or 2(e) o

 

 

 

 

6

Citizenship or Place of Organization
France

 

 

 

Number of
Shares
Beneficially
Owned by
Each
Reporting
Person With

7

Sole Voting Power
0

 

8

Shared Voting Power
590,105

 

9

Sole Dispositive Power
0

 

10

Shared Dispositive Power
590,105

 

 

11

Aggregate Amount Beneficially Owned by Each Reporting Person
590,105

 

 

12

Check Box if the Aggregate Amount in Row (11) Excludes Certain Shares (See Instructions)  o

 

 

13

Percent of Class Represented by Amount in Row (11)
3.1%

 

 

14

Type of Reporting Person (See Instructions)
OO

 

6


 

CUSIP No. 60040X103

 

1

Name of Reporting Person
Bpifrance S.A.

 

 

2

Check the Appropriate Box if a Member of a Group (See Instructions)

 

 

(a)

o

 

 

(b)

o

 

 

3

SEC Use Only

 

 

 

 

4

Source of Funds
WC

 

 

 

 

5

Check Box if Disclosure of Legal Proceedings Is Required Pursuant to Items 2(d) or 2(e) o

 

 

 

 

6

Citizenship or Place of Organization
France

 

 

 

Number of
Shares
Beneficially
Owned by
Each
Reporting
Person With

7

Sole Voting Power
0

 

8

Shared Voting Power
590,105

 

9

Sole Dispositive Power
0

 

10

Shared Dispositive Power
590,105

 

 

11

Aggregate Amount Beneficially Owned by Each Reporting Person
590,105

 

 

12

Check Box if the Aggregate Amount in Row (11) Excludes Certain Shares (See Instructions)  o

 

 

13

Percent of Class Represented by Amount in Row (11)
3.1%

 

 

14

Type of Reporting Person (See Instructions)
OO

 

7


 

Amendment No. 2 to Schedule 13D

 

This Amendment No. 2 (this “Amendment”) is filed jointly by (i) Fonds Innobio FPCI (“Innobio”), a fonds professionnel de capital investissement, (ii) Bpifrance Investissement S.A.S., a French management company (société de gestion) (“Bpifrance Investissement”), (iii) Bpifrance Participations S.A., a société anonyme incorporated under the laws of the Republic of France (“Bpifrance Participations”), (iv) the Caisse des Dépôts, a French special public entity (établissement spécial) (“CDC”), (v) EPIC Bpifrance, a French public institution of industrial and commercial nature (“EPIC”), and (vi) Bpifrance S.A. (“Bpifrance”), a société anonyme incorporated under the laws of the Republic of France (collectively, the “Reporting Persons”).

 

This Amendment further amends (i) the Schedule 13D filed on December 13, 2018 and (ii) the Amendment No. 1 to Schedule 13D filed on December 16, 2019 (collectively, the “Schedule 13D”).

 

Capitalized terms used herein but not otherwise defined herein shall have the respective meanings ascribed thereto in the Schedule 13D, as amended hereby.

 

Item 2. Identity and Background.

 

The penultimate paragraph in Item 4 is hereby amended and replaced as follows:

 

Attached as Appendices A, B, C, D and E to Item 2 is information concerning the executive officers and directors of Bpifrance Investissement, Bpifrance Participations, CDC, EPIC and Bpifrance, respectively, required to be disclosed in response to Item 2 and General Instruction C to Schedule 13D. Innobio is formed under the laws of the Republic of France as a fonds professionnel de capital investissement. Innobio does not have legal capacity under French law or its own personnel, and is represented in all respects by Bpifrance Investissement, its manager.

 

Item 4. Purpose of Transaction.

 

Item 4 is hereby amended and supplemented as follows:

 

Innobio sold an aggregate of 488,565 Common Shares in the open market as follows: (i) 6,200 Common Shares on July 21, 2020; (ii) 50,000 Common Shares on July 22, 2020; and (iii) 432,365 Common Shares on July 23, 2020.  This Amendment is being filed to report the fact that as of July 23, 2020, the Reporting Persons has ceased to be the beneficial owner of more than 5 percent of the Issuer’s Common Shares.

 

Ownership is stated as of July 23, 2020 and the ownership percentages are based on 18,999,701 shares of common stock, $0.001 par value per share (“Common Shares”), outstanding as of May 5, 2020, as disclosed by Millendo Therapeutics, Inc. in its Form 10-Q for the quarterly period ended March 31, 2020, filed on May 8, 2020.

 

All of the Common Shares that are held of record by the Reporting Persons as reported herein were acquired for investment purposes. The Reporting Persons retain the right to change their investment intent, from time to time to acquire additional Common Shares or other securities of the Issuer, or to sell or otherwise dispose of all or part of the Common Shares or other securities of the Issuer, if any, beneficially owned by them, in any manner permitted by law. The Reporting Persons may engage from time to time in ordinary course transactions with financial institutions with respect to the securities described herein.

 

Except as set forth above, none of the Reporting Persons currently has any plans or proposals which would be related to or would result in any of the matters described in Items 4(a)-(j) of the Instructions to Schedule 13D. However, as part of the ongoing evaluation of investment and investment alternatives, the Reporting Persons may consider such matters and, subject to applicable law, may formulate a plan with respect to such matters, and, from time to time, may hold discussions with or make formal proposals to management or the board of directors of the Issuer or other third parties regarding such matters.

 

Item 5. Interest in Securities of the Issuer.

 

Please see Items 5, 6, 7, 8, 9 and 11 of each cover sheet for each filing entity.

 

8


 

As of July 23, 2020, Innobio held directly 590,105 Common Stock. None of Bpifrance, CDC, EPIC, Bpifrance Participations nor Bpifrance Investissement held any Common Stock directly. Bpifrance Investissement may be deemed to be the beneficial owner of the 590,105 Common Stock held by Innobio, through its management of Innobio. Bpifrance Participations may be deemed to be the beneficial owner of 590,105 Common Stock, indirectly through its sole ownership of Bpifrance Investissement. Bpifrance may be deemed to be the beneficial owner of 590,105 Common Stock, indirectly through its sole ownership of Bpifrance Participations, which is the parent company of Bpifrance Investissement. EPIC may be deemed to be the beneficial owner of 590,105 Common Stock, indirectly through its joint ownership and control of Bpifrance. CDC may be deemed to be the beneficial owner of 590,105 Common Stock indirectly through its joint ownership and control of Bpifrance.

 

(a) See also the information contained on the cover pages of this Amendment, which is incorporated herein by reference. The percentage of Common Shares beneficially owned by each Reporting Person is based on 18,999,701 Common Shares of the Issuer outstanding as of May 5, 2020.

 

(b) See the information contained on the cover pages of this Schedule 13D, which is incorporated herein by reference.

 

(c) There have been no reportable transactions with respect to the Common Shares of the Issuer within the last 60 days by the Reporting Persons other than as described in this Amendment No. 2.

 

(d) Not applicable.

 

(e) Not applicable.

 

9


 

SIGNATURE

 

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

 

Dated: July 30, 2020

 

Fonds Innobio FPCI

 

 

 

 

 

 

 

 

By:

/s/ Laurent Arthaud*

 

 

Name:

Laurent Arthaud

 

 

Title:

Associate Director in Charge of Funds (Bpifrance Investissement S.A.S.)

 

 

 

 

 

 

 

 

Bpifrance Investissement S.A.S.

 

 

 

 

 

 

 

 

By:

/s/ Boubakar Dione**

 

 

Name:

Boubakar Dione

 

 

Title:

Group Director of Legal Affairs

 

 

 

 

 

 

 

 

Bpifrance Participations S.A.

 

 

 

 

 

 

 

 

By:

/s/ Boubakar Dione***

 

 

Name:

Boubakar Dione

 

 

Title:

Group Director of Legal Affairs

 

 

 

 

 

 

 

 

Caisse des Dépôts

 

 

 

 

 

 

 

 

By:

/s/ Eric Flamarion****

 

 

Name:

Eric Flamarion

 

 

Title:

Head of Financial Investment Division

 

 

 

 

 

 

 

 

EPIC Bpifrance

 

 

 

 

 

 

 

 

By:

/s/ Boubakar Dione*****

 

 

Name:

Boubakar Dione

 

 

Title:

Group Director of Legal Affairs

 

 

 

 

 

 

 

 

Bpifrance S.A.

 

 

 

 

 

 

 

 

By:

/s/ Boubakar Dione******

 

 

Name:

Boubakar Dione

 

 

Title:

Group Director of Legal Affairs

 

10


 


* Laurent Arthaud is signing on behalf of Fonds Innobio FPCI, by power of attorney from Bpifrance Investissement S.A.S. filed with the Securities and Exchange Commission on October 15, 2019 as Exhibit 99.5 to Schedule 13D filed by Bpifrance Participations S.A. related to DBV Technologies S.A., and hereby incorporated herein by reference.

 

** Boubakar Dione is signing on behalf of Bpifrance Investissement S.A.S. by power of attorney filed with the Securities and Exchange Commission on October 15, 2019 as Exhibit 99.3 to Schedule 13D filed by Bpifrance Participations S.A. related to DBV Technologies S.A., and hereby incorporated herein by reference.

 

*** Boubakar Dione is signing on behalf of Bpifrance Participations S.A. by power of attorney filed with the Securities and Exchange Commission on October 15, 2019 as Exhibit 99.2 to Schedule 13D filed by Bpifrance Participations S.A. related to DBV Technologies S.A., and hereby incorporated herein by reference.

 

**** Eric Flamarion is signing on behalf of Caisse des Dépôts by executive order from the general manager of Caisse des Dépôts previously filed with the Securities and Exchange Commission on April 12, 2018 as Exhibit 99.2 to Schedule 13D filed by Bpifrance Participations related to DBV Technologies S.A., and hereby incorporated herein by reference.

 

***** Boubakar Dione is signing on behalf of EPIC Bpifrance by power of attorney filed with the Securities and Exchange Commission on October 15, 2019 as Exhibit 99.4 to Schedule 13D filed by Bpifrance Participations S.A. related to DBV Technologies S.A., and hereby incorporated herein by reference.

 

****** Boubakar Dione is signing on behalf of Bpifrance S.A. by power of attorney previously filed with the Securities and Exchange Commission on September 7, 2017 as Exhibit 2 to Schedule 13D/A filed by Bpifrance Participations related to Constellium N.V., and hereby incorporated herein by reference.

 

11


 

APPENDIX A

 

Name, business address, present principal occupation or employment and place of citizenship of the directors and executive officers of

 

BPIFRANCE INVESTISSEMENT

 

The name, business address and present principal occupation or employment of each of the directors and executive officers of Bpifrance Investissement are set forth below. The business address of each director and executive officer is Bpifrance Investissement S.A.S., 27-31, avenue du Général Leclerc, 94710 Maisons-Alfort Cedex, France. Unless otherwise indicated, each director and executive officer is a citizen of France.

 

BOARD OF DIRECTORS

 

Name

 

Present Principal Occupation or Employment

 

 

 

NICOLAS DUFOURCQ

 

Director, Chairman, Chief Executive Officer of Bpifrance Participations, and Chief Executive Officer of Bpifrance

 

 

 

VIRGINIE FERNANDES 

 

Director, Head of the Steering Department at Caisse des Dépôts

 

 

 

CATHERINE MAYENOBE

 

Director, Secretary General of the Caisse des Dépôts 

 

 

 

FREDERIC SAINT-GEOURS 

 

Director, President of the supervisory board of SNCF

 

 

 

FRENCH STATE, represented by CHARLES SARRAZIN

 

Director, in charge of shareholding interests in the Service & Finance sectors, Agence des Participations de l’Etat (French State Shareholding Agency) 

 

 

 

CONSTANCE VALIGNY

 

Director, Assistant Director for macroeconomic policies, Direction Générale du Trésor (French Treasury)

 

 

 

BARBARA LAVERNOS

 

Director, Executive Vice-President Operations at L’Oreal 

 

 

 

VICTOIRE AUBRY

 

Director, Chief Financial Officer of Icade

 

 

 

SOPHIE STABILE

 

Founder and CEO of Révérence

 

 

 

JULIEN TOGNOLA

 

Chief, Service of Industry, General Directorate for Companies of the Ministry of Economy and Finance

 

EXECUTIVE OFFICERS

 

Name

 

Present Principal Occupation or Employment

 

 

 

NICOLAS DUFOURCQ

 

Chief Executive Officer

 

 

 

JOSÉ GONZALO

 

Executive Director

 

 

 

PIERRE BENEDETTI

 

Chief Financial Officer 

 

1


 

APPENDIX B

 

Name, business address, present principal occupation or employment and place of citizenship of the directors and executive officers of

 

BPIFRANCE PARTICIPATIONS S.A.

 

The name, business address and present principal occupation or employment of each of the directors and executive officers of Bpifrance Participations S.A. are set forth below. The business address of each director and executive officer is Bpifrance Participations S.A., 27-31, avenue du Général Leclerc, 94710 Maisons-Alfort Cedex, France. Unless otherwise indicated, each director and executive officer is a citizen of France.

 

BOARD OF DIRECTORS

 

Name

 

Present Principal Occupation or Employment

 

 

 

NICOLAS DUFOURCQ

 

Director, Chairman, Chief Executive Officer of Bpifrance Participations, and Chief Executive Officer of Bpifrance

 

 

 

VIRGINIE FERNANDES 

 

Director, Head of the Steering Department at Caisse des Dépôts

 

 

 

CATHERINE MAYENOBE

 

Director, Secretary General of the Caisse des Dépôts Group

 

 

 

FREDERIC SAINT-GEOURS 

 

Director, President of the supervisory board of SNCF

 

 

 

FRENCH STATE, represented by CHARLES SARRAZIN

 

Director, in charge of shareholding interests in the Service & Finance sectors, Agence des Participations de l’Etat (French State Shareholding Agency) 

 

 

 

CONSTANCE VALIGNY

 

Director, Assistant Director for macroeconomic policies, Direction Générale du Trésor (French Treasury)

 

 

 

BARBARA LAVERNOS

 

Director, Executive Vice-President Operations at L’Oreal 

 

 

 

VICTOIRE AUBRY

 

Director, Chief Financial Officer of Icade

 

 

 

SOPHIE STABILE

 

Founder and CEO of Révérence

 

 

 

JULIEN TOGNOLA

 

Chief, Service of Industry, General Directorate for Companies of the Ministry of Economy and Finance

 

EXECUTIVE OFFICERS

 

Name

 

Present Principal Occupation or Employment

 

 

 

NICOLAS DUFOURCQ

 

Chief Executive Officer

 

 

 

JOSÉ GONZALO

 

Executive Director

 

 

 

PIERRE BENEDETTI

 

Chief Financial Officer 

 

2


 

APPENDIX C

 

Name, business address, present principal occupation or employment and place of citizenship of the directors and executive officers of

 

CAISSE DES DÉPÔTS

 

The name, business address and present principal occupation or employment of each of the members of the Management Committee of Caisse des Dépôts are set forth below. The business address of each director and executive officer is Caisse des Dépôts, c/o 56, rue de Lille, 75007 Paris, France. Unless otherwise indicated, each such person is a citizen of France.

 

MANAGEMENT COMMITTEE

 

Name 

 

Present Principal Occupation or Employment 

 

 

 

ERIC LOMBARD

 

Chief Executive Officer of Caisse des Dépôts

 

 

 

OLIVIER SICHEL

 

Deputy Chief Executive Officer of Caisse des Dépôts

 

 

 

NICOLAS DUFOURCQ

 

Chief Executive Officer of Bpifrance

 

 

 

VIRGINIE CHAPRON-DU-JEU

 

Director of Finance for the Caisse des Dépôts Group

 

 

 

PIERRE CHEVALIER

 

Head of Legal and Tax Department

 

 

 

NATHALIE TUBIANA

 

Risk Director of the Caisse des Dépôts Group

 

 

 

OLIVIER MAREUSE

 

Chief Investment officer - Director of Savings Funds at Caisse des Dépôts

 

 

 

CATHERINE MAYENOBE

 

Secretary General of Caisse des Dépôts Group

 

 

 

PAUL PENY

 

Caisse des Dépôts Group Human Resources Director

 

 

 

SOPHIE QUATREHOMME

 

Group Corporate Communications Director

 

 

 

MICHEL YAHIEL

 

Pensions and Solidarity Director

 

3


 

APPENDIX D

 

Name, business address, present principal occupation or employment and place of citizenship of the directors and executive officers of

 

EPIC BPIFRANCE

 

The name, business address and present principal occupation or employment of each of the directors and executive officers of EPIC Bpifrance are set forth below. The business address of each director and executive officer is EPIC Bpifrance, 27-31, avenue du Général Leclerc, 94710 Maisons-Alfort Cedex, France. Unless otherwise indicated, each director and executive officer is a citizen of France.

 

DIRECTORS

 

Name 

 

Present Principal Occupation or Employment 

 

 

 

CHRISTIAN BODIN

 

Chairman, Chief Executive Officer of EPIC Bpifrance

 

 

 

PIERRE-LOUIS AUTIN

 

Director, Head of department SITTAR at the Higher Education, Research and Innovation Ministry

 

 

 

YANN POUËZAT

 

Director, Deputy Director at the Directorate of Financing, Industry and Market of the Ministry of Economy and Finance

 

 

 

ALBAN HAUTIER

 

Director, Deputy Director at the General Directorate for Budget of the Ministry of Economy and Finance

 

 

 

SONIA BEURIER

 

Director

 

 

 

MARIE ANNE LAVERGNE

 

Director

 

 

 

NAOMI PERES

 

Director

 

4


 

APPENDIX E

 

Name, business address, present principal occupation or employment and place of citizenship of the directors and executive officers of

 

BPIFRANCE S.A.

 

The name, business address and present principal occupation or employment of each of the directors and executive officers of Bpifrance S.A. are set forth below. The business address of each director and executive officer is Bpifrance S.A., 27-31, avenue du Général Leclerc, 94710 Maisons-Alfort Cedex, France. Unless otherwise indicated, each director and executive officer is a citizen of France.

 

DIRECTORS

 

Name 

 

Present Principal Occupation or Employment 

 

 

 

ERIC LOMBARD

 

Chairman, Chief Executive Officer of the Caisse des Dépôts

 

 

 

NICOLAS DUFOURCQ

 

Director, Chief Executive Officer of Bpifrance and Director, Chairman and Chief Executive Officer of Bpifrance Participations

 

 

 

GUILLAUME BOUDY

 

Director, General Secretary for Public Investment

 

 

 

MARTIN VIAL

 

Director, Chairman of the Agence des Participations de l’Etat (French State Shareholding Agency)

 

 

 

MARIE DELEAGE

 

Director representing the employees of Bpifrance

 

 

 

PHILIPPE BAYEUX

 

Director representing the employees of Bpifrance

 

 

 

VIRGINIE CHAPRON-DU JEU

 

Director, Group Finance Director of the Caisse des Dépôts

 

 

 

CLAIRE DUMAS

 

Director, Finance Director of Retail Banking France at Société Générale

 

 

 

CLAIRE CHEREMETINSKI

 

Director, Head of Department of Bilateral and International Matters at the French Treasury (Ministry of Economy and Finance)

 

 

 

OLIVIER SICHEL

 

Director, Deputy Chief Executive Officer of the Caisse des Dépôts

 

 

 

BERNARD DELPIT

 

Director, Chief Financial Officer of Safran

 

 

 

ANNABEL ANDRE LAURENT

 

Director

 

 

 

HAROLD HUWART

 

Director

 

 

 

CAROLE ABBEY DUVAL

 

Director

 

 

 

BARBARA LAVERNOS DUPUIS

 

Director

 

 

 

DIANE SIMIU

 

Director

 

5